Cytek Biosciences
CTKB
CTKB
136 hedge funds and large institutions have $415M invested in Cytek Biosciences in 2024 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 67 increasing their positions, 31 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
+7
Holders Change %
+5.43%
% of All Funds
1.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
67
Reduced
31
Closed
13
Calls
$2K
Puts
$5K
Net Calls
-$3K
Net Calls Change
+$2K
Top Buyers
| 1 |
BlackRock
New York
|
$102M |
| 2 |
Citadel Advisors
Miami,
Florida
|
$1.5M |
| 3 |
State Street
Boston,
Massachusetts
|
$23.1M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$1.01M |
| 5 |
Morgan Stanley
New York
|
$5.91M |
Top Sellers
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
$52.6M |
| 2 |
New York State Common Retirement Fund
Albany,
New York
|
$11.6M |
| 3 |
Millennium Management
New York
|
$1.06M |
| 4 |
Goldman Sachs
New York
|
$5.67M |
| 5 |
DM
Deerfield Management
New York
|
$97.4K |
